Ito, Fumiaki http://orcid.org/0000-0002-2274-118X
Li, Ziyuan
Minakhin, Leonid
Chandramouly, Gurushankar
Tyagi, Mrityunjay
Betsch, Robert
Krais, John J. http://orcid.org/0000-0002-3916-3435
Taberi, Bernadette
Vekariya, Umeshkumar
Calbert, Marissa http://orcid.org/0000-0003-3005-8679
Skorski, Tomasz
Johnson, Neil http://orcid.org/0000-0002-0276-0009
Chen, Xiaojiang S. http://orcid.org/0000-0001-9574-0551
Pomerantz, Richard T. http://orcid.org/0000-0003-1194-9871
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM130889, R01GM130889)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Article History
Received: 11 August 2023
Accepted: 5 August 2024
First Online: 14 August 2024
Competing interests
: R.T.P. is a cofounder and CSO of Recombination Therapeutics, LLC. X.S.C. is a cofounder of Recombination Therapeutics, LLC. The remaining authors declare no competing interests.